Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
10/2005
10/26/2005CN1687100A Modification nucleotide and its use
10/25/2005US6958391 Method for purifying 5′-protected 2′-deoxypurine nucleosides
10/25/2005US6958324 Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease
10/25/2005US6958233 Generating S-adenosyl-L-methionine; obtain yeast, incubate in nutrient broth, lyse, filter, elute and recover s-adenosyl-l-methionine
10/20/2005WO2005097816A1 Avermectin and avermectin monosaccharide substituted in the 4”- and 4’- position respectively
10/20/2005WO2005097814A2 Composition and method for inhibiting platelet aggregation
10/20/2005WO2005096706A2 Antibody to 5'-deoxy-5'-methylthioadenosine and uses thereof
10/20/2005WO2004028481A3 Nucleoside derivatives for treating hepatitis c virus infection
10/20/2005US20050234232 Novel compositions for the delivery of negatively charged molecules
10/20/2005US20050233988 Novel compounds
10/20/2005CA2561958A1 Composition and method for inhibiting platelet aggregation
10/19/2005EP1585955A2 Use of isogenic human cancer cells for high-throughput screening and drug discovery
10/19/2005EP1585830A2 Photoactivatable two-stage protective groups for the synthesis of biopolymers
10/19/2005EP1585824A2 Preparation and use of single-stranded transcription substrates for synthesis of transcription products corresponding to target sequences
10/19/2005EP1585529A2 Process for the production of 2'-branched nucleosides
10/19/2005EP1414837B1 Adenosine a3 receptor agonists
10/19/2005EP1385829A4 Nucleic acid labeling compounds
10/19/2005EP1176150B1 Process for the preparation of trifluorothymidine derivatives
10/18/2005US6955915 Solid phase synthesis; photolithography
10/18/2005US6955874 Kits employing oligonucleotide-binding e-tag probes
10/18/2005CA2104399C Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
10/13/2005WO2005095430A1 An improved process for the manufacture of high pure gemcitabine hydrochloride
10/13/2005WO2005094322A2 Effective treatment of tumors and cancer with triciribine and related compounds
10/13/2005WO2005085268A3 Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
10/13/2005WO2005067644A3 Conjugated small molecules
10/13/2005WO2004078994A3 Methods for detection of genetic disorders
10/13/2005CA2561513A1 Effective treatment of tumors and cancer with triciribine and related compounds
10/12/2005EP1584620A1 Process for preparing substituted benzimidazole compounds
10/12/2005EP1583543A2 Methods and therapeutic compositions in the treatment of advanced cancer
10/12/2005EP1370568B1 Chemical compounds
10/12/2005CN1681833A Sir2 products and activities
10/12/2005CN1679568A Use of n-substituted-1, 5-di deoxy-1, 5-imino-d-glucitol compounds for treating hepatitis virus infections
10/12/2005CN1222534C Form VI5, 6-dichloro-2-(isopropylamino)-1-(&beta-L-ribofuranosyl)-1H-benzimidazole
10/11/2005US6953850 Protecting groups for carbohydrate synthesis
10/06/2005WO2005092910A1 Labelling reagents, methods for the synthesis of such reagents and methods for the detection of biological molecules
10/06/2005WO2005092909A1 Processes for producing ribonucleotide analogue with high stereoregularity and deoxyribonucleotide analogue
10/06/2005WO2004009610A3 Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases
10/06/2005US20050222077 Administering to a subject before the onset of an ischemic episode at daily dosages of 1-2 g of free CDP-choline (CITICOLINE)
10/06/2005US20050222056 Heterocyclic compounds and their use in the detection of nucleic acids
10/06/2005US20050221370 Systems and methods for ordering, performing, and reporting genetic screening
10/06/2005CA2558357A1 Labelling reagents, methods for the synthesis of such reagents and methods for the detection of biological molecules
10/05/2005EP1582528A1 Process for producing phosphoroamidite
10/05/2005EP1581547A2 Compounds resistant to metabolic deactivation and methods of use
10/05/2005CN1678622A Process for producing indolopyrrolocarbazole derivative
10/05/2005CN1678621A Modified 2' and 3' -nucleoside produgs for treating flaviridae infections
10/05/2005CN1678326A 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
10/04/2005US6951932 Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines
10/04/2005US6951931 Complexing pyrimidine compound with nucleic acid
09/2005
09/29/2005WO2005090370A1 Pharmacologically active agents containing esterified phosphonates and methods for use thereof
09/29/2005WO2005090349A1 4'-c-substituted 2-haloadenosine derivative
09/29/2005WO2005003295A3 Methods and compositions for maturing dendritic cells utilizing inosine-containing compounds
09/29/2005US20050215819 Method of producing an amide
09/29/2005US20050215527 Antiviral activity and resolution of 2-hydroxymethyl-5- (5-fluorocytosin-1-yl)-1, 3-oxathiolane
09/29/2005US20050215512 Acquired Immune Deficiency Syndrome (AIDS); 2'-deoxy-4'-C-ethynyl-2-fluoroadenosine; anti-HIV activity, particularly against a multi-drug-resistant HIV strain; less cytotoxicity, exhibit resistance to inactivation by adenosine deaminase
09/29/2005US20050215511 Nucleoside compounds for treating viral infections
09/29/2005US20050215510 chemical intermediates used to prepare nucleosides, useful in treating viral infections caused by flaviviruses, such as hepatitis virus
09/29/2005US20050214901 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
09/29/2005US20050214843 Propargyl substituted nucleoside compounds and methods
09/29/2005US20050214828 Using ultrviolet laser excitation and fluorescence to identify regions of hybridization along microarray comprised of immobilized polynucleotides; gene expression analysis; genomics
09/29/2005US20050214759 Enzymatic redox labelling of nucleic acids
09/29/2005US20050214249 Release nitric oxide under physiological conditions and are useful for treating biological disorders
09/29/2005CA2546157A1 Improved expression systems with sec-system secretion
09/28/2005EP1578771A2 Remodeling and glycoconjugation of peptides
09/28/2005EP1578758A2 Purine nucleosides
09/28/2005CN1675235A Partial and full agonists of AL adenosine receptors
09/28/2005CN1675234A Process for producing a ribofuranose
09/28/2005CN1220695C Inhibitors of nucleoside metabolism
09/27/2005US6949640 Method for synthesizing 2-chloro-9-(2-fluoro-β-D-arabinofuranosyl)-9H-purin-6-amine
09/27/2005US6949639 lanthanide(III) chelates
09/27/2005US6949635 use with DNA polymerases that are thermostable or which contain an altered dNMP binding site
09/27/2005US6949522 treating or preventing HIV infection, HBV infection or abnormal cellular proliferation by administering said compounds or the related beta -D and beta -L-2'-halo-4'-thionucleosides
09/27/2005US6949521 Therapeutic azide compounds
09/27/2005US6949341 Diagnosing genetic disorders
09/22/2005WO2005087788A2 Methods for preparation of nucleoside phosphonate esters
09/22/2005US20050209185 Synergistic mixture; administering by inhalation; tiotropium bromide; metered dose inhaler, a dry powder inhaler; asthma, chronic obstructive pulmonary disease
09/22/2005US20050208537 Very large scale immobilized polymer synthesis
09/22/2005DE102004009977A1 New nucleic acid containing fluorescent tricyclic heterocyclic residue, useful as hybridization probes for detection and quantification of nucleic acids
09/21/2005EP1577318A1 Nucleotide derivatives and dna microarray
09/21/2005EP1576138A2 2-branched nucleosides and flaviviridae mutation
09/21/2005EP1575974A1 Modified guanosines having flavouring activity
09/21/2005EP1575973A2 Substitution derivatives of n sp 6 sp -benzyladenosine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds
09/21/2005EP1575972A1 Nucleic acid labeling compounds
09/21/2005EP1575971A1 Process for the production of 3 -nucleoside prodrugs
09/21/2005CN1671728A Novel adenosine analogues and their use as pharmaceutical agents
09/21/2005CN1671727A Anti-viral 7-deaza D-nucleosides and uses thereof
09/21/2005CN1671398A Compositions and methods for treating epithelia and retinal tissue diseases
09/21/2005CN1670029A Thio-phospholipid complex of thio-tegafur in glycerin frame and its synthesis method
09/21/2005CN1219789C Process for preparation of (E)-5-(2-bromovinyl) -2'-deoxyuridine
09/20/2005US6946450 E.g., beta-L-2'-deoxyadenosine
09/20/2005US6946449 5*-sulfoxy-adensoine derivatives used to treat tachycardia and atrial flutter, angina, and myocardial infarction
09/20/2005US6946115 Especially substituted cyclic 1,3- propanyl phosphate, phosphonate and phosphoramidate esters.
09/20/2005CA2226111C In situ preparation of nucleoside phosphoramidites and their use in synthesis of oligonucleotides
09/15/2005WO2005085272A1 Boranophosphate monomer and process for producing oligonucleotide derivative therefrom
09/15/2005WO2005085271A1 NOVEL ARTIFICIAL RNAóS MODIFIED AT THE 2ó-HYDROXYL GROUP
09/15/2005WO2005085270A1 Nucleic acid derivative having pyrrolyl group introduced in 5-position of pyridine ring
09/15/2005WO2005085269A1 Nucleotide derivatives and dna microarray
09/15/2005WO2005085268A2 Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
09/15/2005WO2005084653A2 Adenosine receptor agonists
09/15/2005WO2005084367A2 Photocleavable fluorescent nucleotides for dna sequencing on chip constructed by site-specific coupling chemistry
09/15/2005WO2005084192A2 Novel 2’-c-methyl nucleoside derivatives
1 ... 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 ... 201